EurekAlert! -
17 May 2015 06:00
(Ann & Robert H. Lurie Children's Hospital of Chicago) Groundbreaking treatment that uses two medications that target the most common genetic cause of cystic fibrosis shows lung function improvement and lowers the rate of pulmonary exacerbations.
Share this Article